INTRODUCTION
============

Formins are multidomain proteins that regulate the dynamics and organization of both actin filaments and microtubules (MTs) in a variety of cellular functions requiring coordinated action of the cytoskeleton ([@B7]; [@B14]; [@B11]). Formins nucleate and elongate unbranched actin filaments through the activities of two domains: formin homology 1 (FH1), which binds to actin-bound profilin, and formin homology 2 (FH2), which is involved in actin polymerization. The FH2 domain of formins dimerizes, and this is essential for formin association with the barbed end of growing actin filaments ([@B43]; [@B66]; [@B45]). Of the 15 vertebrate formins, the largest subgroup is the diaphanous-related formins (DRFs), characterized by an N-terminal GTPase-binding domain (GBD), an adjacent diaphanous inhibitory domain (DID), and a C-terminal diaphanous autoregulatory domain (DAD). In many cases, the binding of a Rho-GTPase to the GBD regulates DRF activation by releasing an intramolecular interaction between the DID and the DAD domains that keeps the molecule inactive ([@B1]; [@B2]; [@B45], [@B46]). However, both activation and deactivation steps are often incomplete or kinetically slow when tested with purified components, suggesting that full activation may require convergence of multiple inputs ([@B35]; [@B40]).

Formins also act as positive regulators of MT organization and stability ([@B7]; [@B14]). In many cases, activation of formins generates a subset of selectively stabilized MTs that accumulates posttranslational modifications of tubulin, such as detyrosinated (or Glu) and acetylated tubulin ([@B47], [@B48]; [@B28]; [@B26]; [@B3]; [@B59]). These modified MTs act as specialized tracks for kinesin-dependent transport of cargoes such as vimentin intermediate filaments and endocytic vesicles ([@B33]; [@B36]; [@B52]; [@B32]; [@B64]). In some cases, the formin activity toward MTs is independent of the actin polymerization activity ([@B8]; [@B13]; [@B3]; [@B19]; [@B55]).

The FH2 domain of DRFs binds MTs and is typically implicated in the MT activity, although other domains also interact with MTs ([@B7]; [@B24]). The formin FH2 activity toward MTs seems to be regulated by an autoinhibitory mechanism similar to that toward actin. Active Rho GTP stimulates mDia1's activity to stabilize MTs ([@B47], [@B48]; [@B26], [@B27]), and MT stability can be induced by mDia1 and other formin constructs lacking the DID domain or by expressing their DAD domains ([@B47], [@B48]; [@B3]; [@B59]; [@B19]).

The relatively large number of vertebrate formins raises the question of whether individual formin family members regulate discrete aspects of the actin and MT cytoskeletons. Indeed, it was proposed that individual formin family members might regulate the distinct arrays of actin filaments found in cells ([@B16]), and there is now abundant evidence for this ([@B14]). However, recent studies also reveal that multiple formins collaborate in the regulation of individual actin arrays. For example, FMNL1 and mDia1 have been implicated in the signaling pathway regulating actin assembly during polar body extrusion ([@B65]), and both mDia1 and mDia2 RNAi inhibited nuclear actin assembly in NIH3T3 fibroblasts ([@B5]). INF2 was shown to regulate lamellipodial actin dynamics by opposing Rho/mDia-mediated actin polymerization ([@B57]).

With respect to MTs, which generally form only a single array in cells, there is perhaps an even stronger case for formin collaboration. Most of the formin family members regulate MTs, and there are cases in which multiple formins are required to generate a subset of stable MTs ([@B7]). For example, in breast carcinoma cells, mDia1, mDia2, and mDia3 function nonredundantly for cortical MT capture ([@B19]). In T-cells, FMNL1, mDia1, and the closely related formin INF2 are all necessary for the generation of stable detyrosinated microtubules (Glu MTs), which are essential for centrosome reorientation to the immunological synapse ([@B3]). Nonetheless, whether the formins in these cases exert their effects on MTs sequentially or are required independently is unknown.

Two formins that regulate MT stability, mDia1 and INF2, are known to interact through their DAD and DID domains, respectively ([@B58], [@B57]). The interaction of INF2 with mDia1 has been suggested to negatively regulate mDia1's action on actin polymerization, but whether it is necessary for regulating MTs is unknown ([@B58], [@B57]). In this study, we addressed whether mDia1 and INF2 function individually or together on MTs using the well-established NIH3T3 fibroblast system, in which Rho induces stable MTs through the formin mDia1 ([@B17]; [@B47]). We find that mDia1 functions upstream of INF2, stimulating its localization to MTs. The interaction between mDia1's DAD and INF2's DID is required for stable MT formation. Both formins interact with the adaptor protein IQGAP1, and IQGAP1 is required for stable MT formation, INF2 localization to MTs, and promotion of mDia1 and INF2 interaction in vivo. These results suggest a novel mechanism of formin activation in which mDia1 activates INF2's MT-stabilizing activity through the scaffolding function of IQGAP1.

RESULTS
=======

INF2 is required for lysophosphatidic acid stimulation of Glu MTs
-----------------------------------------------------------------

We tested the role of INF2, implicated in the stabilization of MTs in vitro ([@B24]) and T-cells ([@B3]), in the formation of Glu MTs in the well-characterized NIH3T3 fibroblast system. Reducing INF2 expression with two different small interfering RNA (siRNA) oligonucleotides significantly inhibited the percentage of cells with Glu MTs without noticeably affecting dynamic tyrosinated (Tyr) MTs ([Figure 1, A--C](#F1){ref-type="fig"}). The reduction in Glu MTs was comparable to that observed in mDia1 knockdown, and knocking down both formins did not further reduce Glu MTs (Supplemental Figure S1, A and B). Unlike in T-cells, knocking down mDia1, INF2, or both did not affect centrosome reorientation in cells at the edge of wounded monolayers ([Figure 1, C and D](#F1){ref-type="fig"}, and Supplemental Figure S1B). Of note, knocking down either formin also resulted in a significant increase in MT dynamicity by increasing MT growth and shrinkage rates and decreasing pausing ([Figure 1E](#F1){ref-type="fig"}, Supplemental Table S1, and Supplemental Movies S1--S3).

![INF2 regulates Glu MTs and MT dynamics but not centrosome orientation in NIH3T3 fibroblasts. (A) Immunoblot analysis of INF2, mDia1, and GAPDH (loading control) in NIH3T3 fibroblasts treated with noncoding control (NC), mDia1, or two INF2 siRNAs for the indicated time (in hours). (B) Glu and Tyr tubulin immunostaining of cells treated as in A and fixed 48 h after siRNA transfection. (C) Quantification of cells with Glu MTs (top) or oriented centrosome (bottom) treated as in A. Data are mean ± SD from four independent experiments (\>200 cells/experiment). \*\**p* \< 0.001 calculated by chi-square test. (D) Tyr tubulin, pericentrin, and 4',6-diamidino-2-phenylindole (DAPI) staining of cells treated as in A and fixed 48 h after siRNA transfection. Arrows indicate the location of the centrosome in cells at the wound edge. (E) MT dynamics in mDia1- and INF2-knockdown NIH3T3 fibroblasts. Level of knockdown of mDia1 or INF2 in cells treated with the indicated siRNAs at the time movies were recorded. Growth and shrinkage rates and percentage of pausing of MTs in tagRFP-C4 tubulin stably expressing NIH3T3 fibroblasts transfected for 72 h with noncoding control siRNA (NC) or siRNA to either mDia1 (simDia1) or INF2 (siINF2). Data are mean ± SEM. \*\*\*\**p* \< 0.0001, \*\*\**p* \< 0.001 by two-tailed Student's *t* test. No asterisk, *p* \> 0.05. Bars, 20 μm.](1797fig1){#F1}

Active forms of INF2 induce stable Glu MTs
------------------------------------------

Next we tested the ability of INF2 to form de novo stable Glu MTs in serum-starved cells that have few Glu MTs ([@B17]; [@B47]). Overexpression of full-length INF2 only weakly induced Glu MTs, suggesting that INF2's MT stabilizing activity is negatively regulated by intramolecular inhibition. Indeed, fragments of INF2 containing the FH2 domain but lacking the N-terminal regulatory domain (FH2DAD, FH1FH2, and FH2) all induced stable Glu MTs above background levels ([Figure 2, A--C](#F2){ref-type="fig"}), indicating that the FH2 alone is capable of generating Glu MTs. The FH2DAD was the only fragment that induced Glu MTs extending to the cell periphery, suggesting that peripheral MT stabilization may require the DAD domain, perhaps to induce endogenous INF2. Consistent with this idea, expression of INF2-DAD stimulated Glu MT formation ([Figure 2, D and E](#F2){ref-type="fig"}). The Glu MTs induced by INF2-DAD, FH1FH2, and FH2 alone were all resistant to nocodazole-induced depolymerization, confirming their stability ([Figure 2, F--I](#F2){ref-type="fig"}). INF2 may also be regulated negatively by membrane association, as expression of FH2-DAD constructs containing a C-terminal consensus motif for prenylation did not strongly induce Glu MTs (Supplemental Figure S2).

![INF2 induces stable Glu MTs through its FH2 domain. (A) Schematic of the INF2 fragments used in this study. (B) Myc (INF2), Glu, and Tyr tubulin staining of starved cells expressing indicated myc-tagged INF2 fragments. Arrows, expressing cells. (C) Quantification of cells treated as in B that exhibited Glu MTs. (D) GFP, Glu, and Tyr tubulin staining of starved cells expressing GFP or GFP-INF2-DAD. Arrow indicates Glu MTs in cell expressing GFP-INF2-DAD. (E) Quantification of cells treated as in D that exhibited Glu MTs. (F) DM1A and GFP staining of starved cells expressing GFP-INF2-DAD and treated with 2 μM nocodazole (30 min). Arrow, expressing cell. (G) Quantification of cells treated as in F that exhibited DM1A-labeled MTs. (H) DM1A (MTs) and myc staining of starved cells expressing myc-INF2-FH2 or myc-INF2-FH1FH2 and treated with nocodazole as in F. Arrows, expressing cell. (I) Quantification of cells treated as in H that exhibited DM1A-labeled MTs. In C, E, G, and H, data are mean ± SD from three independent experiments (\>50 cells/experiment). \**p* \< 0.05, \*\**p* \< 0.001 by chi-square test. Bars, 20 μm.](1797fig2){#F2}

Mutation of three leucine residues (Leu^976^, Leu^977^, Leu^986^) to alanine in the DAD of INF2 abrogates its in vitro actin depolymerization but not polymerization activity ([@B15]). Conversely, mutation of Lys^792^ in the FH2 domain of INF2 to alanine diminishes actin polymerization activity without affecting actin severing and depolymerization ([@B51]). We introduced the same mutations alone or in combination in green fluorescent protein (GFP)--INF2 and found that the triple Leu^976,977,986^, Lys^792^, or the combined mutants rescued stable Glu MT formation in INF2-depleted cells as well as wild-type INF2 (Supplemental Figure S3A). To confirm this, we expressed an INF2-FH2 construct containing the Ile^643^/Lys^792^ mutant shown to severely affect actin polymerization in vitro. Both the Lys^792^ and the Ile^643^/Lys^792^ double mutant retained their ability to induce Glu MTs in serum-starved cells (Supplemental Figure S3B). Thus, similarly to closely related mDia ([@B8]; [@B13]; [@B3]; [@B19]) and as observed in T-cells ([@B3]), INF2 activities toward actin polymerization and MT stabilization can be segregated.

INF2 localizes to Glu MTs in a lysophosphatidic acid--dependent manner
----------------------------------------------------------------------

INF2 fragments containing the FH2 domain bind to MTs directly and stabilize them against depolymerization in vitro (Supplemental Figure S4; [@B24]), indicating that MT stabilization in cells might be related to direct MT binding. To test this, we analyzed the localization of endogenous INF2 in starved cells before and after stimulation with lysophosphatidic acid (LPA) to induce stable Glu MTs. Epifluorescence microscopy showed that INF2 accumulated in a pericentriolar region coincident with Glu MTs only in cells stimulated with LPA ([Figure 3A](#F3){ref-type="fig"}). Of importance, this localization was strongly reduced in cells treated with high doses of nocodazole to induce complete depolymerization of dynamic and stable MTs, suggesting that INF2 associated with MTs. To critically test this possibility, we used total internal reflection fluorescence (TIRF) microscopy, which illuminates a narrow (∼100--200 nm) section of the ventral surface of the cell and was previously used to localize Glu MTs at the ventral surface ([@B63]). By TIRF microscopy, we found that INF2 appeared as linear streaks after LPA stimulation that colocalized preferentially with Glu MTs ([Figure 3, B and C](#F3){ref-type="fig"}, and Supplemental Figure S5). LPA-dependent association of INF2 with MTs was confirmed by enrichment of the INF2 signal on Triton X-100--resistant Glu MTs by Western blot analysis and immunofluorescence of the insoluble cytoskeletal fraction ([Figure 3, D and E](#F3){ref-type="fig"}). Together these results show that INF2 is required for LPA stimulation of stable Glu MTs in NIH3T3 fibroblasts, its activity toward MTs depends on its FH2 domain (but not its actin polymerization activity), and it localizes to Glu MTs in an LPA-dependent manner.

![LPA stimulates INF2 localization to Glu MTs. (A) Epifluorescence microscopy of endogenous INF2 and Glu tubulin immunostaining of starved NIH3T3 fibroblasts treated with LPA or LPA and nocodazole (10 μM, 2 h). Arrows indicate accumulated INF2 staining near Glu MTs. Inset, partial colocalization of INF2 (red) with Glu MTs (green). (B) TIRF microscopy of LPA-stimulated NIH3T3 fibroblasts immunostained for INF2, Glu, and Tyr tubulin. The boxed region is shown at higher magnification in C. (C) Merged image of the boxed region in B and linescan showing quantification of INF2, Glu, and Tyr tubulin fluorescence along the white line depicted in the merged image. (D) Western blot analysis of Triton X-100--soluble (S) and --insoluble (P) fractions from NIH3T3 fibroblasts before and after LPA addition. PDI is a marker for the soluble fraction. The ratio of INF2 in the fractions is shown. (E) INF2 and Glu tubulin immunostaining of LPA-stimulated NIH3T3 fibroblasts after brief extraction with Triton X-100 before fixation. Boxes show the region used for the high-magnification merge shown below. Bars, 20 μm.](1797fig3){#F3}

INF2 functions downstream of mDia1
----------------------------------

The involvement of two formins in the stabilization of Glu MTs downstream of LPA raised two possibilities: 1) the two formins function in series, with both of them regulating the same subset of MTs and one of them functioning upstream of the other, or 2) the two formins function in parallel, with both of them inducing a subset of stable Glu MTs. In the former case, one of the two formins should depend on the activation of the other for its promotion of MT stability. We tested this possibility by specifically activating each formin by expressing its DAD domain in cells that had been previously depleted of either mDia1 or INF2 by siRNA oligonucleotides. DAD domains activate endogenous DRFs by competing with the intramolecular inhibitory interaction between the DAD and DID domains of the endogenous formin ([@B1]). As expected, expression of the DAD domains of both formins induced Glu MTs in starved cells but not in cells depleted of their parent molecules ([Figure 4A](#F4){ref-type="fig"}). Of interest, whereas INF2-DAD induced Glu MTs in mDia1-depleted cells, mDia1-DAD failed to induce Glu MTs in INF2-depleted cells. These results suggest that INF2 activity is downstream of mDia1 and that activation of INF2 is sufficient to induce Glu MTs in the absence of mDia1.

![mDia1 induction of stable MTs requires INF2. (A) Quantification of Glu MTs in serum-starved NIH3T3 fibroblasts treated with NC, mDia1, or INF2 siRNAs before activation of each formin by expression of mDia1-DAD or INF2-DAD. (B) MT dynamics in NIH3T3 fibroblasts stably expressing RFP-tubulin and treated with NC, mDia1, or INF2 siRNAs before expressing mDia1-DAD or INF2-DAD. Data are mean ± SEM. Statistics were performed by two-way ANOVA with Tukey's multiple comparison test comparing different groups to NC GFP. \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001. (C) INF2 and MT (Tyr tubulin) immunostaining of NIH3T3 fibroblasts depleted of mDia1 imaged by TIRF microscopy. Bottom, higher magnifications of the boxed regions shown in the top. (D) GFP and Glu tubulin immunostaining of NIH3T3 fibroblasts depleted of INF2 and expressing GFP-WT INF2 or GFP-INF2 E184K and R218Q variants that do not bind to mDia1. Arrows indicate transfected cells. (E) Quantification of cells with Glu MTs treated as in D. (F) Quantification of Glu MTs in cells depleted of mDia1 and transfected with GFP, GFP mDia1, or GFP mDia1ΔDAD, which lacks the region that binds to INF2. Data are mean ± SD from three independent experiments (\>200 cells/experiment). \**p* \< 0.05, \*\**p* \< 0.001; ns, not significant; calculated by chi-square test. Bars, 20 μm.](1797fig4){#F4}

We also examined whether the DAD domains could rescue the increased MT dynamicity observed in cells depleted of each formin ([Figure 1E](#F1){ref-type="fig"}). Neither DAD domain rescued the increased MT growth or shrinkage rates or decreased pausing in cells depleted of their parent molecules ([Figure 4B](#F4){ref-type="fig"}). Nonetheless, INF2-DAD significantly suppressed these parameters in mDia1-depleted cells, and mDia1-DAD failed to suppress them ([Figure 4B](#F4){ref-type="fig"}, Supplemental Table S2, and Supplemental Movies S4--S12). These results lend further support to the idea that INF2 functions downstream of mDia1 in regulating MTs.

To test the relationship between mDia1 and INF2 further, we examined the localization of each formin in the absence of the other. We detected no obvious alteration in the localization of endogenous mDia1 in INF2-depleted cells (Supplemental Figure S6). However, the accumulation of INF2 along the length of MTs as detected by TIRF was lost in cells deprived of mDia1 ([Figure 4C](#F4){ref-type="fig"}). Thus the localization of INF2 on MTs requires mDia1.

The DID of INF2 has been shown to interact directly with the DAD of mDia1 ([@B58]), potentially providing an explanation for how activated mDia1 may function upstream to activate INF2. To test this idea, we took advantage of variants in INF2's DID that cause focal segmental glomerulosclerosis (FSGS) and disrupt this interaction ([@B12]; [@B58]). We attempted to rescue Glu MT formation in INF2-depleted cells by expressing wild-type INF2 or these disease variants. Unlike their wild-type counterpart, neither E184K nor R218Q INF2 restored levels of Glu MTs in INF2-depleted cells ([Figure 4, D and E](#F4){ref-type="fig"}). Consistent with this result, mDia1Δ DAD, which cannot bind to INF2 ([@B58]), failed to rescue MT stability in cells depleted of mDia1 ([Figure 4F](#F4){ref-type="fig"}). Together these results strongly support a role for mDia1 in the regulation of INF2 activity toward MTs and suggest that the interaction between mDia1-DAD and INF2-DID is required for this regulation.

IQGAP1 is required for formin-induced Glu MTs
---------------------------------------------

Despite the fact that mDia1's DAD interacts directly with INF2's DID in vitro ([@B58]), its expression did not induce Glu MTs in serum-starved cells in the absence of mDia1 ([Figure 4B](#F4){ref-type="fig"}). This may reflect the low affinity of interaction between mDia1-DAD and INF2-DID ([@B58]). We hypothesized that in vivo full-length mDia1 was necessary to bring its DAD into the proximity of INF2, perhaps by binding a protein that bridges the two formins. IQGAP1 is such a candidate bridging molecule: it interacts specifically with activated mDia1, whose DAD is freed from interaction with its DID ([@B10]), and it has been implicated in regulating MT capture and stability ([@B23]; [@B61]; [@B64]). IQGAP1 was also reported to coimmunoprecipitate with INF2, although the nature of the interaction was not characterized ([@B9]). To examine a possible role for IQGAP1 in stimulating INF2's MT activity by active mDia1, we first determined whether IQGAP1 was required to generate stable Glu MTs. Compared to wild-type (WT) mouse embryonic fibroblasts (MEFs), MEFs from IQGAP1-knockout (KO) mice exhibited almost no detectable Glu MTs by immunofluorescence or Glu tubulin by Western blot ([Figure 5, A and B](#F5){ref-type="fig"}). This phenotype represented defective MT stabilization, as shown by lack of acetylated MTs, another tubulin posttranslational modification associated with MT stability, and the finding that Glu MT levels could be rescued with the MT stabilizer Taxol (Supplemental Figure S7). Lack of Glu MTs was not due to reduced levels of mDia1 or INF2, which in fact were up-regulated compared with WT MEFs ([Figure 5B](#F5){ref-type="fig"}). Of importance, reexpression of IQGAP1 in IQGAP1 KO cells rescued Glu MT levels in these cells (Supplemental Figure S8, A and B). Acute depletion of IQGAP1 by siRNA oligonucleotides also reduced Glu tubulin levels biochemically and Glu MTs by immunofluorescence ([Figure 5, C and E](#F5){ref-type="fig"}). Conversely, overexpression of IQGAP1 in serum-starved cells induced formation of Glu MTs ([Figure 5, F and G](#F5){ref-type="fig"}). Thus IQGAP1 is required for LPA-stimulated Glu MT formation and is sufficient to induce Glu MTs when overexpressed.

![IQGAP1 is required for formin-mediated induction of Glu MTs. (A) Immunostaining of Glu and Tyr tubulin in IQGAP1 WT and KO MEFs. (B) Immunoblot of IQGAP1, INF2, mDia1, and Glu tubulin in IQGAP1 WT and KO MEFs. Actin is a loading control. (C) Immunoblot of IQGAP1 and Glu tubulin in NIH3T3 fibroblasts treated with noncoding (NC) or IQGAP1 siRNA. Vinculin is a loading control. (D) Immunostaining of IQGAP1, Glu, and Tyr tubulin in NIH3T3 fibroblasts treated with NC or IQGAP1 siRNA. (E) Quantification of Glu MTs in cells treated as in D. (F) Immunostaining of GFP, Glu, and Tyr tubulin in starved NIH3T3 fibroblasts expressing GFP-IQGAP1. (G) Quantification of cells with Glu MTs treated as in F. (H) TIRF microscopy of NIH3T3 fibroblasts treated with NC or IQGAP1 siRNA and immunostained for INF2 and Tyr tubulin (MTs). Far right, higher- magnifications of INF2 staining of the regions shown in the boxes. (I) Quantification of cells with Glu MTs after depleting IQGAP1 and transfecting either mDia1-DAD or INF2-DAD to activate endogenous formins. (J) Quantification of cells with Glu MTs in cells transfected with GFP or GFP-IQGAP1 after treatment with NC, mDia1, or INF2 siRNAs. Data are mean ± SD from three independent experiments (\>200 cells/experiment). \*\**p* \< 0.001 calculated by chi-square test. Bars, 20 μm.](1797fig5){#F5}

As in cells depleted of mDia1, INF2 failed to localize to MTs in cells depleted of IQGAP1 ([Figure 5H](#F5){ref-type="fig"}). However, whereas we detected INF2 along the length of stable Glu MTs, endogenous IQGAP1 only localized to cortical dynamic MTs in NIH3T3 cells (Supplemental Figure S9, A--C). Reexpression of IQGAP1 in IQGAP1 KO MEFs induced INF2 localization to Glu MTs (Supplemental Figure S8C). This result suggests that IQGAP1 may be necessary to activate INF2's MT-stabilizing activity. To test this, we determined whether IQGAP1 was required for the induction of Glu MTs by mDia1's DAD domain. mDia1-DAD domain failed to induce Glu MTs when expressed in cells depleted of IQGAP1 ([Figure 5I](#F5){ref-type="fig"}). In addition, IQGAP1 overexpression failed to induce Glu MTs in mDia1- or INF2-depleted cells ([Figure 5J](#F5){ref-type="fig"}). These observations suggest that IQGAP1 is necessary for mDia1's activation of INF2 and that IQGAP1 cannot stimulate MT stability without the formins.

We confirmed that endogenous INF2 and IQGAP1 interacted by coimmunoprecipitation ([Figure 6A](#F6){ref-type="fig"}). Active mDia1 interacts with the C-terminus of IQGAP1 ([@B10]), so it was of interest to determine whether INF2 interacted with the same or a different site on IQGAP1. We found that full-length INF2 and INF2-FH2C, but not INF2-N, interacted with IQGAP1 by pull-down assays using recombinant or overexpressed proteins ([Figure 6B-D](#F6){ref-type="fig"}). INF2-FH2C interacted with an N-terminal fragment of IQGAP1 but not a C-fragment ([Figure 6E](#F6){ref-type="fig"}). Of importance, using recombinant proteins, we found that the interaction between INF2-FH2C and IQGAP1-N was direct ([Figure 6F](#F6){ref-type="fig"}). Together these data show that each of the three components, mDia1, INF2, and IQGAP1, associate via nonoverlapping sites, potentially forming a trimeric complex ([Figure 6G](#F6){ref-type="fig"}).

![IQGAP1 interacts directly with INF2. (A) Coimmunoprecipitation of INF2 and IQGAP1 from whole-cell lysates of NIH3T3 fibroblasts using nonimmune IgG or INF2 antibody. (B) Schematic of the fragments of INF2 and IQGAP1 used in C--F. (C) Immunoblot analysis of endogenous IQGAP1 in pull downs from whole-cell lysates using GST-INF2-N, GST-INF2-FH2C, and GST alone. (D) Coimmunoprecipitation of IQGAP1-GFP and Myc-INF2 (INF2) or Myc-INF2-FH2C using nonimmune IgG (Rb IgG) or GFP antibody. Both Myc-tagged (m-INF2) and endogenous INF2 (e-INF2) were detected by Western blotting using INF2 antibody. (E) Immunoblot analysis of pull downs from whole-cell lysates expressing GFP-IQGAP1-N or -C using GST-INF2-FH2C or GST alone. (F) Coomassie staining of binding reactions with GST-IQGAP1-N or GST alone (2 μM) with indicated concentrations (μM) of untagged INF2-FH2C. (G) Schematic of the interactions between mDia1, INF2, and IQGAP1.](1797fig6){#F6}

We attempted to isolate a complex by sucrose gradient fractionation and coimmunoprecipitation but did not detect one, suggesting that it may form transiently or may not resist cell lysis. To assess whether this complex might form in cells, we used in situ proximity ligation (PLA) assays that generate punctate signals when antibodies to the two interacting species are within 30--40 nm ([@B56]). First, we confirmed that the PLA signal (measured as number of puncta per cell) depended on the presence of mDia1 and INF2 primary antibodies and mDia1 expression ([Figure 7, A--D](#F7){ref-type="fig"}). Next we observed that INF2/mDia1 PLA puncta increased upon LPA addition ([Figure 7, E and F](#F7){ref-type="fig"}) and that INF2/mDia1 puncta were significantly reduced in immortalized MEFs from IQGAP1 KO mice ([Figure 7, G and H](#F7){ref-type="fig"}). These results indicate that LPA induces the association of INF2 and mDia1 in cells and that this depends on IQGAP1.

![IQGAP1 is required for the interaction of mDia1 and INF2 stimulated by LPA. (A) Images from PLA assays of serum-grown NIH3T3 fibroblasts using antibodies against mDia1 and INF2 or as controls, leaving out mDia1 antibody or both antibodies. Red puncta indicate interaction between mDia1 and INF2; nuclei are stained with DAPI. (B) Quantification of PLA puncta/cell (±SEM) in samples prepared as in A; \>50 cells/sample. (C) PLA puncta in NIH3T3 fibroblasts depleted of mDia1 by siRNA. (D) Quantification of PLA puncta/cell (±SEM) in samples prepared as in C; \>140 cells/sample. (E) PLA puncta in starved NIH3T3 fibroblasts stimulated with LPA. (F) Quantification of PLA puncta/cell (±SEM) in samples prepared as in E; \>80 cells/sample. (G) PLA puncta in IQGAP1 WT and KO MEFs. (H) Quantification of PLA puncta/cell (±SEM) in samples prepared as in G; \>80 cells/sample. \*\*\**p* \< 0.0001 by Mann--Whitney test. Bars, 20 μm.](1797fig7){#F7}

DISCUSSION
==========

One of the crucial questions for how formins regulate MT stability is whether their action is direct or is mediated by downstream events. A number of formins, including mDia1, mDia2, and INF2, have been shown to bind to MTs and enhance their stability in vitro ([@B8]; [@B24]; [@B59]) and in vivo ([@B47]; [@B63]; [@B8]; [@B3]; [@B59]; [@B19]). Previously mDia1 was shown to interact with the MT plus end--tracking proteins EB1 and APC, suggesting that the formation of a complex might be involved in generating stable MTs ([@B28]; [@B63]). Here we found that a second formin, INF2, implicated in MT stability in T-cells, was also required for MT stability and regulation of MT dynamics in NIH3T3 fibroblasts and, critically, functioned downstream of mDia1. Either formin was necessary to reduce MT growth and shrinkage rates while increasing pausing, suggesting that at steady state, Glu MT stability is critically dependent on reduction of MT dynamics as if stabilized by a "capping" mechanism indicated by previous observations ([@B17]; [@B30]; [@B47]). Consistent with a more proximal effect on MTs, INF2 localized to stable MTs, and this localization required mDia1 and IQGAP1. These data suggest a revised model for MT stabilization by formins in which one formin (mDia1) activates a second formin (INF2), allowing it to bind to and stabilize MTs through its FH2 domain.

In addition to functional and localization data, this sequential model for formin action on MTs is supported by interaction data on mDia1, INF2, and IQGAP1. A previous study showed that the DAD domain of mDia1 interacted with the DID domain of INF2 ([@B58]), and we found that this interaction was essential for inducing stable Glu MTs. Of importance, mDia1's DAD was unable to suppress MT dynamicity or induce Glu MTs in the absence of endogenous mDia1, indicating that in vivo mDia1's DAD needed to be presented to INF2 in the context of full-length mDia1. Given the previously described interactions of INF2 and active mDia1 with IQGAP1 ([@B10]; [@B9]), we suspected that IQGAP1 may act to bring mDia1 and INF2 together to facilitate interaction between their DAD and DID. Indeed, our data showing that IQGAP1 is required for induction of stable Glu MTs by LPA or the DAD domains of either formin strongly support such a model. In addition, our studies show that INF2 and IQGAP1 interact through sites that would allow simultaneous binding of mDia1. Despite this, we were unable to isolate a stable complex containing the three proteins. Nonetheless, we used PLA to show that mDia1 and INF2 interacted in vivo and that this interaction was stimulated by LPA and required IQGAP1. Together these results suggest that the interaction between mDia1, INF2, and IQGAP1 is transient and may release INF2 once it has been activated.

To our knowledge, these data are the first to suggest that formins function in series to regulate the formation of a cytoskeletal array. Previous studies implicated multiple formins in regulating both the actin and MT cytoskeletons but did not show that two formins functioned sequentially to induce a single cytoskeletal change. This result raises the question of whether INF2 is a downstream effector of mDia1 only or whether other formins can converge in the activation of INF2 to regulate MT stability, thus allowing activation of MT stability downstream of multiple stimuli. It is also possible that the mDia1-INF2 pair can be activated to regulate actin structures in addition to stable MT arrays. For example, INF2's DID interaction with mDia1's DAD was shown to inhibit the polymerization of actin by mDia1 ([@B58], [@B57]). Formins are known to interact with other regulators of the cytoskeleton, including MT plus end--tracking proteins EB1 and APC ([@B28]), MT-modifying enzyme HDAC6 ([@B20]), and actin regulators APC ([@B42]; [@B62]; [@B44]) and spire ([@B54]; [@B18]; [@B50]). Perhaps the selected recruitment of these cytoskeletal regulators downstream of distinct signaling pathways contributes to the formation of distinct cytoskeletal arrays.

Unlike loss of MT stability, no effect on centrosome reorientation was detected in either mDia1- or INF2-silenced cells, suggesting that, unlike T-cells, the activity of these formins on Glu MTs has no functional consequence on the polarization of the centrosome/nuclear axis in NIH3T3 cells at the edge of a wounded monolayer. T-cells seem to depend on Glu MTs for centrosome orientation, but repeated studies show that this not the case in fibroblasts ([@B47]; [@B6]). We cannot fully explain this discrepancy, but it may reflect differences in the mechanisms of centrosome orientation in the two systems: in NIH3T3 fibroblasts, the nucleus is moved rearward to orient the centrosome ([@B25]; [@B37]; [@B38]), whereas in T-cells, the centrosome is moved ([@B53]).

Our work is not the first to implicate IQGAP1 as a scaffolding protein for regulators of MTs. For example, CLIP-170 and APC interact with IQGAP1 to mediate the transient capture of MTs at cortical regions ([@B61]). Similarly, CLASP2, which also interacts with IQGAP1, is involved in MT stability in migrating cells ([@B21]) and might regulate the association of IQGAP1 with MTs and EB1 ([@B60]). Induction of Glu MTs in starved cells was shown to occur upon GSK3β inhibition caused by mDia-mediated novel protein kinase C activation, suggesting positive regulation of CLASP2/IQGAP1 complex formation by formin function ([@B22]). Comprehensive in vitro and in vivo analysis will be required to understand the sequence of the association of all these proteins and whether they assemble into a MT "stabilosome."

Mutations in INF2's DID domain that disrupt the interaction between INF2 and mDia1 have been implicated in the etiology of FSGS and Charcot--Marie--Tooth (CMT) diseases ([@B12]; [@B9]; [@B58], [@B57]). Our results show that these mutations also prevent the formation of stable Glu MTs, raising the possibility that lack of MT stability may contribute to these diseases. CMT hereditary neuropathy refers to a group of disorders caused by a variety of mutations affecting axonal function, the insulating myelin coating, or both, whereas FSGS is primarily a glomerular disorder that causes renal dysfunction and in which the affected genes encode regulators of the actin cytoskeleton in podocytes. Although loss of INF2-mediated inhibition of Rho/mDia-driven actin polymerization in the foot process of podocytes is one mechanism proposed for mutant INF2 in the pathogenesis of FSGS ([@B58], [@B57]), the precise role of INF2 mutations in the etiology of CMT and FSGS is largely unexplained. MTs are known to maintain the shape and integrity of podocyte major processes, and disruption of MT stability is predicted to indirectly affect the delivery of regulators of actin dynamics in the foot processes. In addition, loss of MT stability by mutant INF2 might equally be crucial for maintenance of axonal integrity at the onset of CMT. Examination of MT stability in tissue or cells isolated from patients may reveal whether loss of MT stability by mutated INF2 correlates with the onset of neuropathy and/or kidney dysfunction.

MATERIALS AND METHODS
=====================

Plasmids and reagents
---------------------

DNA constructs expressing the following INF2 fragments tagged with c-myc or glutathione *S*-transferase (GST) at their amino terminus were described previously ([@B4], [@B3]; [@B39]): myc-FH2DAD (amino acids \[aa\] 532--1010); myc-FH1FH2 (aa 266--955); myc--WT FH2 (aa 532--955) or with the Lys^792^Ala or double Lys^792^Ala and Ile^643^Ala mutations; myc--C-terminus of INF2-1 (splicing variant 1; aa 1013--1249); GST-DID (aa 1--265); GST-FH2DAD (aa 532--1010); and GST-C1 (aa 1013--1249). DNA constructs expressing GFP fused to INF2-1 or to INF2 proteins with the single Lys^792^Ala, triple Leu^976^, Leu^977^, Leu^986^Ala, or combined mutations (Lys^792^Ala/Leu^976^, Leu^977^, Leu^986^Ala) were made by cloning INF2 sequences from the corresponding constructs in pSport6 ([@B39]) in the pEGFP-C1 expression vector. DNA constructs expressing FH2DADC fragments with mutations in the CAAX box of INF2-1 (FH2DADC-AIVQ and FH2DADC-CIVL) or with the carboxyl-terminal end of INF2-1 substituted by that of INF2-2 (splicing variant 2 without CAAX box; FH2DAD-N) were achieved by PCR using a perfectly matched 5′ oligonucleotide primer and a 3′ oligonucleotide primer containing the appropriate modification and cloning the amplification fragment in the plasmid pCR3.1 (ThermoFisher Scientific, Waltham, MA). GFP- or myc-tagged DAD of INF2 was made by cloning the amplified fragment containing the DAD domain of INF2 (aa 956--1010) in the pCR3.1 or pGFP-C1 vectors. GST-FH2DADC1 (aa 532--1249) was made by cloning the myc-tagged FH2DADC1 fragment of INF2-1 in pGEX-4T-1. His-tagged-mDia1-FH2DAD (aa 748-1203) was a kind gift of Robert Grosse (University of Heidelberg, Heidelberg, Germany; [@B10]). GFP mDia1 lacking the DAD domain was generated using standard PCR procedures using a template kindly provided by S. Narumiya (Kyoto University, Kyoto, Japan). GFP-INF2-E184K and -R218Q mutants were constructed using a QuikChange Site-Directed Mutagenesis kit (Stratagene, San Diego, CA) according to the manufacturer's protocols. Cherry-mDia1FH1COOH was generated as described ([@B44]). GFP-IQGAP1, GFP-IQGAP1-C (1950--1657), and -N (1--550), as well as GST-IQGAP1-N and -C plasmids, were kindly provided by Geri Kreitzer (Cornell University, Ithaca, NY) and George Bloom (University of Virginia, Charlottesville, VA). All constructs were verified by sequencing. All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise noted. LPA was obtained from Avanti (Alabaster, AL).

Antibodies
----------

Antibodies used include polyclonal rabbit 301 generated against INF2 peptide SVKEGAQRKWAALKEKLGPC (amino acids 2--19), mouse monoclonal supernatant (1E4) against the same sequence, and rabbit polyclonal anti-INF2 (Proteintech, Rosemont, IL). The INF2 peptide was synthesized in an automated peptide synthesizer (Abimed, Langerfeld, Germany) coupled to keyhole limpet hemocyanin (ThermoFisher Scientific) and injected in rabbits and mice. Spleen cells from immunized mice were fused to myeloma cells and a hybridoma clone (E4) selected that produced antibody that recognized INF2 in extracts from Cos-7 cells transiently expressing myc-tagged INF2. The specificity of rabbit antiserum and the E4 monoclonal antibody was assayed by immunoblot (IB) and immunofluorescence (IF) analyses. Other antibodies used include mDia1 (clone 51; 1:100 for IF, 1:500 for WB; BD Biosciences, San Jose, CA), rat anti--tyrosinated tubulin (YL-1/2; 1:10 for IF, 1:1000 for IB), rabbit anti-Glu tubulin (1:500 for IF, 1:10,000 for IB; [@B29]), mouse (1:8000; ThermoFisher Scientific) or rabbit (FL-335; 1:1000; Santa Cruz Biotechnology, Dallas, TX) anti--glyceraldehyde 3-phosphate dehydrogenase, mouse anti--β-actin (C4; 1:1000), mouse anti-pericentrin (1:100; BD Biosciences), mouse anti-PDI (1:1000 for IB; Stressgen, Victoria, Canada), mouse anti-Myc (9E10; 1:100; Santa Cruz Biotechnology), mouse anti--acetylated tubulin (6-11B-1; 1:100), mouse anti--α-tubulin (DM1A; 1:1000), rabbit anti-GFP (Millipore, Billerica, MA), mouse (10 μg/ml for IF, 1 μg/ml for IB) and rabbit (1:250 for IF, 1:1000 for IB) anti-IQGAP1 antibodies (kind gifts of George Bloom), and rabbit anti-IQGAP1 (H-109; 1:100 for IF, 1:500 for IB; Santa Cruz Biotechnology). For endogenous immunolocalization, a mouse anti-IQGAP1 from BD Biosciences was used (1:100).

Protein purification, GST pull-down, and direct protein-binding assays
----------------------------------------------------------------------

GST-tagged proteins (GST, GST-INF2-FH2DADC, GST-INF2-FH2DAD, GST-INF2-C, and GST-INF2-N) were expressed in *Escherichia coli* BL-21 and purified on agarose-coupled glutathione (GE Healthcare, Little Chalfont, United Kingdom) according to the manufacturer's protocols. Histidine-mDia1-FH2DAD was purified as described ([@B8]). Purified proteins were dialyzed into in HKCL buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH.7.4, and 140 mM KCl) using Slide-A-Lyzer dialysis cassettes (10,000 MWCO; ThermoFisher Scientific) overnight at 4°C. GST-pull-down assays were carried out by incubating glutathione-agarose--bound purified GST-tagged proteins (20 μg) with precleared whole-cell lysates prepared using NP-40 lysis buffer (20 mM Tris-HCl, pH 7.4, 200 mM NaCl, 1 mM EDTA, 0.5% NP-40, 1 mM dithiothreitol \[DTT\], phenylmethylsulfonyl fluoride \[PMSF\], and protease and phosphatase inhibitor cocktails from ThermoFisher Scientific) from cells transfected with the indicated GFP constructs. Complexes were allowed to form for 2 h at 4°C and eluted from beads with SDS loading buffer after three washes with NP-40 lysis buffer. Direct protein-binding assays were performed in HKCL buffer plus 1 mM DTT by incubating the indicated amounts of GST or GST-IQGAP1-N with untagged INF2-FH2C plus or minus untagged INF2-DID for 30 min at room temperature. Untagged proteins were generated by overnight incubation with thrombin at 4°C, followed by elution from benzoamidine agarose to eliminate thrombin from the final protein solution. Protein complexes were isolated by adding glutathione-agarose for 1 h at 4°C, followed by several washes in HKCL before final elution in SDS loading buffer.

Coimmunoprecipitation assays
----------------------------

NIH3T3 fibroblasts grown in 10-cm dishes (at least two dishes per sample) were lysed at confluence by scraping with EBC buffer (50 mM Tris-HCl, pH 8, 120 mM NaCl, 0.5% NP-40, 1 mM ethylene glycol tetraacetic acid, 1 mM NaF, 500 μM Na~3~VO~4~, 1 mM PMSF, and proteasome and phosphatase inhibitor cocktails) for 30 min on ice, and cell lysates were precleared by centrifugation at 130,000 × *g* at 4°C. Each precleared sample was incubated with the primary antibody or preimmune immunoglobulin G (IgG) serum (∼10 μg/sample) for 4 h at 4°C. A premade mixture of protein A--plus protein G--Sepharose 4B beads equilibrated in EBC buffer (50/50 slurry) was then added to each sample and incubated for 2 h at 4°C. Immunocomplexes were washed 3× with EBC buffer using spin filter tubes (ThermoFisher Scientific) and eluted in hot SDS loading buffer before boiling and loading onto SDS--PAGE for Western blot analysis.

Cell culture and microinjection
-------------------------------

NIH3T3 fibroblasts were grown in DMEM and 10% calf serum as previously described ([@B17]; [@B47]). WT and KO IQGAP1MEFs ([@B31]) were grown in DMEM plus 10% fetal calf serum. For drug or microinjection experiments, cells were grown to confluence on acid-washed coverslips, serum starved or not for 48 h, and wounded 30 min before treatment or cDNA injection. For plasmid microinjection, cDNAs were resuspended in HKCL buffer at 50--200 μg/ml, precleared at 10,000 × *g* for 30 min at 4°C, and microinjected into nuclei of cells selected randomly from the edges of a wounded monolayer 2 h before fixation and immunostaining.

siRNA, cDNA transfection, and Western blot analysis
---------------------------------------------------

NIH3T3 fibroblasts were transfected with siRNA oligonucleotides (Shangai GenePharma, Shanghai, China) using RNAiMax according to manufacturer's protocols (Invitrogen). siRNA duplexes targeting mDia1 and INF2 were based on previously published sequences ([@B6]; [@B39]). IQGAP1 siRNA (5′-GGA­UAAAUUUAACGUGGAUdTdT-3′) was generated through the Dharmacon (Lafayette, CO) siRNA design algorithm ([www.thermoscientificbio.com/design-center/](http://www.thermoscientificbio.com/design-center/)), and a scrambled noncoding sequence provided by the manufacturer was used as a negative control. Knockdown efficiency and percentage of cells with Glu MTs or oriented centrosomes were analyzed 48 or 72 h after transfection as indicated in the figures. For cDNA expression for immunoprecipitation studies, NIH3T3 fibroblasts were transfected at 30% confluence in growth medium with Lipofectamine Plus (ThermoFisher Scientific) according to the manufacturer's protocols and allowed to express for 24 h. For cDNA expression in cells previously silenced by siRNA transfection, cells were transfected 48 h after siRNA transfection and allowed to express an additional 24 h before fixation. For Western blot analysis, unless otherwise stated, cells were lysed in RIPA buffer (1% Triton X-100, 50 mM Tris, pH 7.4, 150 mM NaCl, 0.1% SDS, 0.5% Na deoxycholate, 1 mM PMSF, and protease and phosphatase inhibitors), normalized for protein concentration by bicinchoninic acid assay, boiled in SDS sample buffer, separated by SDS--PAGE, and Western blotted. Incubation with primary antibodies was followed by incubation with the appropriate IR680- or IR800-conjugated secondary antibodies (1:10,000; Rockland Immunochemicals, Pottstown, PA), and final data acquisition and quantification were performed using an Odyssey imaging system (Li-COR Biosciences, Lincoln, NE).

Epifluorescence and TIRF microscopy
-----------------------------------

NIH3T3 fibroblasts grown on coverslips were typically fixed in methanol at −20°C for 10 min to preserve MT integrity and rehydrated in TBS (10 mM Tris-buffered saline, pH 7.4). Secondary antibodies were from Jackson ImmunoResearch Laboratories (West Grove, PA) and were preabsorbed to minimize cross-reaction with other species. Immunostained samples were observed using a Nikon TE2000 microscope with a 60×/1.45 objective and an Orca II ER charge-coupled device (CCD) camera (Hamamatsu, Hamamatsu, Japan) controlled by MetaMorph software. In experiments assessing Glu MT levels, injected cells or 200 cells randomly chosen at the edge of an artificial wound were scored as positive if \>10 MTs were brightly stained by the Glu antibody. This cutoff was selected based on previous considerations ([@B17]; [@B47]). For centrosome orientation, cells at the edge of an artificial wound were randomly selected and scored as previously described ([@B49]). Both counts were preformed blinded. Data were quantified and expressed as means ± SEM from at least three independent experiments (\>200 cells/experiment).

MT dynamics
-----------

NIH3T3 fibroblasts were infected with pMSCV-puro-tagRFP-C4 α-tubulin retrovirus to generate a red fluorescent protein (RFP)--tubulin stably expressing cell line. RFP-tubulin NIH3T3 cells were transfected with noncoding control siRNA (NC) or either siRNA to silence Dia1 (simDia1) or INF2 (siINF2) for 72 or 48 h and then transfected with enhanced GFP control, mDia1 DAD-EGFP (aa 1180--1255), or INF2 DAD-EGFP (aa 955--1010) for another 24 h. Live imaging of MT dynamics in transfected cells was performed at 37°C and 5% CO~2~ for 5 min (5 s/frame) with a 100× PlanApo objective (numerical aperture 1.45) and an iXon X3 CCD camera (Andor, Belfast, United Kingdom) on a Nikon Eclipse Ti microscope controlled by Nikon's NIS-Elements software (Nikon, Tokyo, Japan). Movies were analyzed by ImageJ using a manual tracking plug-in. Statistics among groups were performed by two-way analysis of variance (ANOVA test). \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001.

Preparation of detergent-resistant cell fraction
------------------------------------------------

Confluent starved cells before and after treatment with LPA for 2 h were scraped and washed twice in ice-cold phosphate-buffered saline before lysis in ice-cold fractionation buffer (10 mM 1,4-piperazinediethanesulfonic acid, pH 6.8, 50 mM NaCl, 3 mM MgCl~2~, 300 mM sucrose, 0.5% Triton X-100, 1 mM DTT, and protease inhibitors from ThermoFisher Scientific) for 20 min on ice. The cell lysate was centrifuged at 4°C for 3 min at 1500 × *g* to isolate the soluble from the Triton X-100--insoluble fraction. Denaturing SDS loading buffer was added and matching aliquots of each protein boiled and loaded onto SDS--PAGE for Western blot analysis.

In situ ligation proximity assays
---------------------------------

Samples were fixed in methanol at −20°C and processed for Duolink in situ amplification as suggested by the manufacturer's protocol (Onlink Bioscience, Uppsala, Sweden) using mouse anti-mDia1 (clone 51, 1:100; BD Biosciences) and rabbit ant-INF2 (301). Random images of stained samples were captured by epifluorescence microscopy using a 60× oil immersion objective, and PLA signals were quantified using custom software. Briefly, cell boundaries were drawn, and the number of PLA puncta and their sizes (in pixels) were determined by the software using thresholded images. Data were exported to Microsoft Excel or GraphPad Prism 4.0 for statistical analysis and plotting. All PLA experiments were performed at least three times, and for each experiment, 10 images were taken per condition using identical microscope and camera settings. In each experiment, a minimum of 50 cells were counted per condition and used for analysis.

Other methods
-------------

See Supplemental Materials and Methods for MT binding and stability assays and confocal microscopy.
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CMT

:   Charcot--Marie--Tooth

DAD

:   diaphanous autoregulatory domain

DID

:   diaphanous inhibitory domain

DRF

:   diaphanous-related formin

FH1/2

:   formin homology 1/2

FSGS

:   focal segmental glomerulosclerosis

GBD

:   GTPase-binding domain

GFP

:   green fluorescent protein

Glu MT

:   detyrosinated microtubule; IgG, immunoglobulin G

LPA

:   lysophosphatidic acid

MT

:   microtubule

PLA

:   in situ proximity ligation

siRNA

:   small interfering RNA

TIRF

:   total internal reflection fluorescence.
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